glp 1 with kidney disease Potential kidney-protective and other effects of GLP-1 receptor Glucagon-Like Peptide-1 Receptor Agonist Use

According to the group of authors, these polyagonists are in all likelihood the next step towards a cure for diabetes and obesity. Comparable to bariatric surgery The authors report on various polyagonists that are currently being researched in clinical studies and show improved efficacy with each new generation. The latest triple agonists attack both the glucose-dependent insulinotropic peptide receptor (GIPR) and the receptors for glucagon-like peptide 1 (GLP1) and glucagon (GCG, a hormone from the pancreas)

One such treatment is Semaglutide GLP-1, a medication often used to aid with weight loss and the management of type 2 diabetes

That said, theres no harm in combining the two supplements, so it cant hurt to try

UK Researchers are excited about the potential of these peptides to treat a wide range of conditions, from tissue injuries and skin regeneration to metabolic disorders and muscle wasting

Initiation of semaglutide therapy Patient Profile 56-year-old female Hgb A1C 8% Blood pressure 138/86 Fasting glucose 150 Social/ Lifestyle history Single/ Lives alone Sedentary work The diet contains significant amounts of processed foods No regular physical activity (I try to go for a walk some days at lunch time) High School graduate Chief Complaint: Im having a hard time controlling my blood sugar levels